MSK2 inhibits p53 activity in the absence of stress

Susana Llanos1, Ana Cuadrado, Manuel Serrano

  • 1Spanish National Cancer Research Centre, Madrid, Spain. sllanos@cnio.es

Science Signaling
|October 3, 2009
PubMed

Insights

Mitogen- and stress-activated kinase 2 (MSK2) inhibits the transcription factor p53. Upon apoptotic stimuli, MSK2 degrades, relieving p53 inhibition and promoting apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Mitogen- and stress-activated kinase 2 (MSK2) is known to regulate cellular responses.
  • The transcription factor p53 plays a critical role in tumor suppression and apoptosis.
  • The precise mechanisms by which MSK2 influences p53 activity remain incompletely understood.

Purpose of the Study:

  • To elucidate the mechanisms by which MSK2 inhibits the transcriptional activity of p53.
  • To investigate the role of MSK2 in regulating p53 target gene expression under basal and stress conditions.
  • To determine how MSK2-mediated inhibition of p53 is regulated during apoptosis.

Main Methods:

  • Investigated MSK2's effect on p53 target gene expression.
  • Assessed the role of MSK2 kinase activity and upstream signaling in p53 inhibition.
  • Examined the interaction between MSK2, p300, and the Noxa promoter.
  • Monitored MSK2 degradation during apoptotic stimuli.

Main Results:

  • MSK2 selectively suppressed a subset of p53 target genes in the absence of stress.
  • This basal inhibition was independent of MSK2 kinase activity and upstream signaling.
  • MSK2 interacted with and inhibited the p53 coactivator p300, associating with the Noxa promoter.
  • Apoptotic stimuli led to MSK2 degradation, releasing p53 inhibition and enabling Noxa transactivation.

Conclusions:

  • MSK2 employs a novel mechanism to inhibit p53 transcriptional activity.
  • MSK2 directly interacts with p300 to modulate p53 coactivation.
  • Regulation of MSK2 stability is crucial for p53-mediated apoptosis in response to stress.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.